{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:54:44Z","timestamp":1794959684599,"version":"4.9.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The myeloid neoplasms encompass acute myeloid leukemia, myelodysplastic syndromes and myeloproliferative neoplasms. Most cases arise from the shared ancestor of clonal hematopoiesis (CH). Here we analyze data from 454,340 UK Biobank participants, of whom 1,808 developed a myeloid neoplasm 0\u201315\u2009years after recruitment. We describe the differences in CH mutational landscapes and hematology\/biochemistry test parameters among individuals that later develop myeloid neoplasms (pre-MN) versus controls, finding that disease-specific changes are detectable years before diagnosis. By analyzing differences between \u2018pre-MN\u2019 and controls, we develop and validate Cox regression models quantifying the risk of progression to each myeloid neoplasm subtype. We construct \u2018MN-predict\u2019, a web application that generates time-dependent predictions with the input of basic blood tests and genetic data. Our study demonstrates that many individuals that develop myeloid neoplasms can be identified years in advance and provides a framework for disease-specific prognostication that will be of substantial use to researchers and physicians.<\/jats:p>","DOI":"10.1038\/s41588-023-01472-1","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T16:05:27Z","timestamp":1692893127000},"page":"1523-1530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":136,"title":["Multiparameter prediction of myeloid neoplasia risk"],"prefix":"10.1038","volume":"55","author":[{"given":"Muxin","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthi Cheloor","family":"Kovilakam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Marando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7452-2536","authenticated-orcid":false,"given":"Clea","family":"Barcena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Mohorianu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2314-1426","authenticated-orcid":false,"given":"Siddhartha P.","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete A.","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Gerstung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Cargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1460-1611","authenticated-orcid":false,"given":"Luca","family":"Malcovati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7793-6291","authenticated-orcid":false,"given":"Pedro M.","family":"Quiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-8022","authenticated-orcid":false,"given":"George S.","family":"Vassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"1472_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.canep.2016.03.011","volume":"42","author":"E Roman","year":"2016","unstructured":"Roman, E. et al. Myeloid malignancies in the real-world: occurrence, progression and survival in the UK\u2019s population-based Haematological Malignancy Research Network 2004\u201315. Cancer Epidemiol. 42, 186\u2013198 (2016).","journal-title":"Cancer Epidemiol."},{"key":"1472_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3324\/haematol.2012.064014","volume":"98","author":"M Maynadie","year":"2013","unstructured":"Maynadie, M. et al. Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study. Haematologica 98, 230\u2013238 (2013).","journal-title":"Haematologica"},{"key":"1472_CR3","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477\u20132487 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1472_CR4","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488\u20132498 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1472_CR5","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/nm.3733","volume":"20","author":"M Xie","year":"2014","unstructured":"Xie, M. et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med. 20, 1472\u20131478 (2014).","journal-title":"Nat. Med."},{"key":"1472_CR6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.celrep.2015.02.005","volume":"10","author":"T McKerrell","year":"2015","unstructured":"McKerrell, T. et al. Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Rep. 10, 1239\u20131245 (2015).","journal-title":"Cell Rep."},{"key":"1472_CR7","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/s41591-018-0081-z","volume":"24","author":"P Desai","year":"2018","unstructured":"Desai, P. et al. Somatic mutations precede acute myeloid leukemia years before diagnosis. Nat. Med. 24, 1015\u20131023 (2018).","journal-title":"Nat. Med."},{"key":"1472_CR8","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41586-018-0317-6","volume":"559","author":"S Abelson","year":"2018","unstructured":"Abelson, S. et al. Prediction of acute myeloid leukaemia risk in healthy individuals. Nature 559, 400\u2013404 (2018).","journal-title":"Nature"},{"key":"1472_CR9","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-018-0114-7","volume":"24","author":"RS Sellar","year":"2018","unstructured":"Sellar, R. S., Jaiswal, S. & Ebert, B. L. Predicting progression to AML. Nat. Med. 24, 904\u2013906 (2018).","journal-title":"Nat. Med."},{"key":"1472_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41576-019-0127-1","volume":"20","author":"V Tam","year":"2019","unstructured":"Tam, V. et al. Benefits and limitations of genome-wide association studies. Nat. Rev. Genet. 20, 467\u2013484 (2019).","journal-title":"Nat. Rev. Genet."},{"key":"1472_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","volume":"586","author":"AG Bick","year":"2020","unstructured":"Bick, A. G. et al. Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature 586, 763\u2013768 (2020).","journal-title":"Nature"},{"key":"1472_CR12","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41586-019-1765-3","volume":"575","author":"DJ Thompson","year":"2019","unstructured":"Thompson, D. J. et al. Genetic predisposition to mosaic Y chromosome loss in blood. Nature 575, 652\u2013657 (2019).","journal-title":"Nature"},{"key":"1472_CR13","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41588-022-01121-z","volume":"54","author":"SP Kar","year":"2022","unstructured":"Kar, S. P. et al. Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis. Nat. Genet. 54, 1155\u20131166 (2022).","journal-title":"Nat. Genet."},{"key":"1472_CR14","unstructured":"Van der Auwera, G. A. & O\u2019Connor, B. D. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra (O\u2019Reilly, 2020)."},{"key":"1472_CR15","doi-asserted-by":"publisher","unstructured":"Vlasschaert, C. et al. A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic datasets. Blood https:\/\/doi.org\/10.1182\/blood.2022018825 (2023).","DOI":"10.1182\/blood.2022018825"},{"key":"1472_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jmoldx.2021.10.013","volume":"24","author":"CA Miller","year":"2022","unstructured":"Miller, C. A. et al. Failure to detect mutations in U2AF1 due to changes in the GRCh38 reference sequence. J. Mol. Diagn. 24, 219\u2013223 (2022).","journal-title":"J. Mol. Diagn."},{"key":"1472_CR17","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber, D. A. et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood 140, 1200\u20131228 (2022).","journal-title":"Blood"},{"key":"1472_CR18","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1182\/bloodadvances.2017007047","volume":"1","author":"T McKerrell","year":"2017","unstructured":"McKerrell, T. et al. JAK2 V617F hematopoietic clones are present several years prior to MPN diagnosis and follow different expansion kinetics. Blood Adv. 1, 968\u2013971 (2017).","journal-title":"Blood Adv."},{"key":"1472_CR19","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/s41591-021-01521-4","volume":"27","author":"A Niroula","year":"2021","unstructured":"Niroula, A. et al. Distinction of lymphoid and myeloid clonal hematopoiesis. Nat. Med. 27, 1921\u20131927 (2021).","journal-title":"Nat. Med."},{"key":"1472_CR20","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1126\/science.aax5863","volume":"367","author":"HJ Uckelmann","year":"2020","unstructured":"Uckelmann, H. J. et al. Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia. Science 367, 586\u2013590 (2020).","journal-title":"Science"},{"key":"1472_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1182\/blood.2019001113","volume":"134","author":"S Cordua","year":"2019","unstructured":"Cordua, S. et al. Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population. Blood 134, 469\u2013479 (2019).","journal-title":"Blood"},{"key":"1472_CR22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/joim.13019","volume":"287","author":"M Hultcrantz","year":"2020","unstructured":"Hultcrantz, M. et al. Incidence of myeloproliferative neoplasms\u2014trends by subgroup and age in a population-based study in Sweden. J. Intern. Med. 287, 448\u2013454 (2020).","journal-title":"J. Intern. Med."},{"key":"1472_CR23","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200310","author":"LD Weeks","year":"2023","unstructured":"Weeks, L. D. et al. Prediction of risk for myeloid malignancy in clonal hematopoiesis. NEJM Evid., https:\/\/doi.org\/10.1056\/EVIDoa2200310 (2023).","journal-title":"NEJM Evid."},{"key":"1472_CR24","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry, A. et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am. J. Epidemiol. 186, 1026\u20131034 (2017).","journal-title":"Am. J. Epidemiol."},{"key":"1472_CR25","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1182\/bloodadvances.2021005927","volume":"6","author":"PM Quiros","year":"2022","unstructured":"Quiros, P. M., Gu, M., Barcena, C., Iyer, V. & Vassiliou, G. S. NPM1 gene mutations can be confidently identified in blood DNA months before de novo AML onset. Blood Adv. 6, 2409\u20132413 (2022).","journal-title":"Blood Adv."},{"key":"1472_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-020-2430-6","volume":"584","author":"PR Loh","year":"2020","unstructured":"Loh, P. R., Genovese, G. & McCarroll, S. A. Monogenic and polygenic inheritance become instruments for clonal selection. Nature 584, 136\u2013141 (2020).","journal-title":"Nature"},{"key":"1472_CR27","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury, J. D. et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia 36, 1703\u20131719 (2022).","journal-title":"Leukemia"},{"key":"1472_CR28","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","volume":"247","author":"FE Harrell Jr.","year":"1982","unstructured":"Harrell, F. E. Jr., Califf, R. M., Pryor, D. B., Lee, K. L. & Rosati, R. A. Evaluating the yield of medical tests. JAMA 247, 2543\u20132546 (1982).","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1038\/s41588-023-01532-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000}}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-023-01472-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-023-01472-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-023-01472-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T16:20:35Z","timestamp":1695140435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-023-01472-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1472"],"URL":"https:\/\/doi.org\/10.1038\/s41588-023-01472-1","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41588-023-01532-6","asserted-by":"object"}]},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"assertion":[{"value":"19 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41588-023-01532-6","URL":"https:\/\/doi.org\/10.1038\/s41588-023-01532-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.S.V. is a consultant to STRM.BIO and holds a research grant from AstraZeneca for research unrelated to that presented here. M.A.F. is an employee and stockholder of AstraZeneca. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}